Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.22
-0.09 (-6.87%)
At close: Aug 14, 2025, 3:59 PM
1.23
0.80%
After-hours: Aug 14, 2025, 06:45 PM EDT

Standard BioTools Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
174.43M 106.34M 97.95M 130.58M
Cost of Revenue
90.17M 55.89M 60.9M 61.21M
Gross Profit
84.26M 50.45M 37.05M 69.37M
Operating Income
-175.24M -76.6M -116.2M -67.46M
Interest Income
20.2M n/a 2.23M n/a
Pretax Income
-138.31M -74.2M -192.93M -63.66M
Net Income
-138.88M -74.66M -190.1M -59.24M
Selling & General & Admin
156.61M 87.54M 114.76M 98.89M
Research & Development
62.41M 25.95M 38.5M 37.94M
Other Expenses
40.48M 13.56M n/a n/a
Operating Expenses
259.5M 127.05M 153.26M 136.83M
Interest Expense
3.32M 4.57M 4.33M 3.82M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
349.67M 182.94M 214.15M 198.04M
Income Tax Expense
573K 452K -2.83M -4.42M
Shares Outstanding (Basic)
353.25M 79.16M 78.31M 75.79M
Shares Outstanding (Diluted)
353.25M 79.16M 78.31M 75.79M
EPS (Basic)
-0.52 -0.94 -2.43 -0.78
EPS (Diluted)
-0.52 -0.94 -2.43 -0.78
EBITDA
-118.14M -54.46M -173.57M -43.77M
EBIT
-135M -69.64M -188.6M -59.84M
Depreciation & Amortization
16.86M 15.18M 15.03M 16.07M